B
NVS icon

Bailard’s Novartis NVS Stock Holding History

Bailard’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Sell
13,282
-1,144
-8% -$175K 0.05% 231
2025
Q4 		$1.99M Buy
14,426
+2,305
+19% +$302K 0.04% 229
2025
Q3 		$1.55M Buy
12,121
+1,418
+13% +$173K 0.03% 272
2025
Q2 		$1.3M Buy
10,703
+580
+6% +$65.4K 0.03% 291
2025
Q1 		$1.13M Buy
10,123
+4,160
+70% +$443K 0.03% 290
2024
Q4 		$580K Buy
5,963
+283
+5% +$30.2K 0.01% 431
2024
Q3 		$653K Buy
5,680
+1,593
+39% +$181K 0.02% 414
2024
Q2 		$435K Buy
4,087
+661
+19% +$66.4K 0.01% 479
2024
Q1 		$331K Buy
+3,426
New +$351K 0.01% 542
2021
Q1 		– Sell
-9,088
Closed -$858K – 727
2020
Q4 		$858K Buy
9,088
+550
+6% +$48.1K 0.04% 236
2020
Q3 		$742K Buy
8,538
+485
+6% +$42K 0.04% 234
2020
Q2 		$703K Buy
8,053
+3,102
+63% +$268K 0.04% 225
2020
Q1 		$408K Sell
4,951
-956
-16% -$85.3K 0.03% 258
2019
Q4 		$559K Sell
5,907
-33
-0.6% -$2.96K 0.03% 257
2019
Q3 		$516K Buy
5,940
+600
+11% +$53.9K 0.03% 263
2019
Q2 		$487K Buy
5,340
+172
+3% +$14.6K 0.03% 290
2019
Q1 		$446K Buy
+5,168
New +$415K 0.03% 324

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bailard's NVS Position: Q1 2026 in Review

Bailard reduced its Novartis (NVS) stake by 7.9% in Q1 2026, selling an estimated $175K and leaving 13,282 shares worth $2.03M. The position accounts for 0.05% of the portfolio, ranked #231.

Bailard first reported a position in NVS in Q1 2019 and has held it in 17 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Bailard held 13,282 shares of Novartis worth $2.03M as of Q1 2026.
  • Bailard sold 1,144 Novartis shares in Q1 2026, an estimated $175K.
  • Novartis made up 0.05% of Bailard's portfolio in Q1 2026, its #231 holding.
  • Bailard first reported a position in Novartis in Q1 2019 and has held it in 17 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.